EDWARD GRAVISS to Heart Transplantation
This is a "connection" page, showing publications EDWARD GRAVISS has written about Heart Transplantation.
Connection Strength
0.827
-
Effectiveness of combined plasma cell therapy and costimulation blockade based desensitization regimen in heart transplant candidates. Clin Transplant. 2024 02; 38(2):e15249.
Score: 0.141
-
Intravenous immunoglobulin in heart transplant recipients with mild to moderate hypogammaglobulinemia and infection. Clin Transplant. 2022 04; 36(4):e14571.
Score: 0.123
-
Outcomes of Heart Transplant Recipients with Class II Obesity: A United Network for Organ Sharing Database Analysis. J Surg Res. 2022 04; 272:69-78.
Score: 0.122
-
A multi-institutional retrospective analysis on impact of RV acute mechanical support timing after LVAD implantation on 1-year mortality and predictors of RV acute mechanical support weaning. J Heart Lung Transplant. 2022 02; 41(2):244-254.
Score: 0.121
-
Remote versus early corticosteroid wean outcomes in heart transplant recipients in the contemporary era. Clin Transplant. 2021 08; 35(8):e14382.
Score: 0.118
-
Waitlist and post-transplant outcomes in patients listed with intra-aortic balloon pump for heart transplant: United Network for Organ Sharing registry. Int J Artif Organs. 2020 Sep; 43(9):606-613.
Score: 0.108
-
Risk Stratification of Patients With Current Generation Continuous-Flow Left Ventricular Assist Devices Being Bridged to Heart Transplantation. ASAIO J. 2018 Mar/Apr; 64(2):196-202.
Score: 0.094